The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment

Exclusion Criteria

• •1. Repeated revascularization surgery.
• •2. Critical and urgent cardiovascular conditions: tissue ischemia stage III-IV, stroke, acute coronary syndrome, myocardial infarction, chronic heart failure III and IV class NYHA (New York Heart Association).
• •3. Other critical and urgent conditions not associated with cardiovascular diseases, including the need for urgent interventions, chronic renal failure stages IV-V (creatinine clearance \< 30 ml / min according to the Cockcroft-Gault Equation)
• •4. High degree of disability of the patient (4 or higher points on the modified Rankin scale).
• •5. History of systemic autoimmune diseases.
• •6. Significant weight loss (\> 10% of body weight in the previous year) of unknown etiology.
• •7. Conditions that limit adherence to participation in the study (dementia, neuropsychiatric diseases, drug addiction, alcoholism, etc.).
• •8. Participation in other clinical studies (or use of investigational substances) within 3 months prior to study entry.
• •9. Patients with malignant tumors, including the postoperative period with chemotherapy and / or radiation therapy.
• •10. Carriers of HIV or viral hepatitis
• •11. Pregnancy or breast feeding
• •12. Refusal to participate in the study.